[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.250. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1937

PNEUMONIA DUE TO PNEUMOCOCCUS TYPE VII (COOPER): SPECIFIC SERUM TREATMENT

Author Affiliations

Clinical Professor of Medicine, New York University College of Medicine; Visiting Physician, Harlem Hospital; Statistical Secretary, Littauer Pneumonia Research Fund of New York University, Harlem Hospital Station NEW YORK

From the Littauer Pneumonia Research Fund of the New York University, College of Medicine; from the Medical Service, Harlem Hospital (Department of Hospitals), and from the Research Laboratories (Department of Health).

Arch Intern Med (Chic). 1937;60(2):179-192. doi:10.1001/archinte.1937.00180020003001
Abstract

In our series Pneumococcus type VII (Cooper) was responsible for 6.5 per cent of the cases of pneumococcic pneumonia in adults and for 2.4 per cent of the cases of pneumococcic pneumonia in children.

During the seven years from 1928 to 1935 there were observed in the wards of the Harlem Hospital 218 patients with pneumonia due to Pneumococcus type VII. Of these, 200 were adults and 18 were children. The number of cases and the relative incidence of this type of pneumonia varied from year to year. In the series for adults in the years 1929-1930 and 1930-1931 the cases of pneumonia due to Pneumococcus type VII were relatively most numerous, 37 cases (9 per cent). In the year 1934-1935 this type occurred in 24 cases, only 4.6 per cent of the total number of cases of pneumonia for that year.1

Of the adult patients with type VII

×